Showing results (1071-1080 of 1,712) with videos related to

Sort By:
Pageof 172
Clinical Nephrology|April 28, 2010
Depression and health-related quality of life in maintenance hemodialysis patientsH C Park, H-B Yoon, M-J Son, et al.
Cell Stem Cell|September 4, 2018
Autocrine Mfge8 Signaling Prevents Developmental Exhaustion of the Adult Neural Stem Cell PoolYi Zhou, Allison M Bond, Jamie E Shade, et al.
Journal of Drug Targeting|August 27, 2010
Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluationMyung J Kang, Bo G Kim, Jae Y Eum, et al.
Cell Death & Disease|May 25, 2013
Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signalsH-M Yun, J H Oh, J-H Shim, et al.
Immunopharmacology and Immunotoxicology|May 23, 2002
ERK MAP Kinase is required in 1,25(OH)2D3-induced differentiation in human osteoblastsH J Chae, B J Jeong, M S Ha, et al.
The Journal of Biological Chemistry|September 3, 1999
Crystal structure of a maltogenic amylase provides insights into a catalytic versatilityJ S Kim, S S Cha, H J Kim, et al.
Transplantation Proceedings|November 18, 2009
Influence of human allogenic bone marrow and cord blood-derived mesenchymal stem cell secreting trophic factors on ATP (adenosine-5'-triphosphate)/ADP (adenosine-5'-diphosphate) ratio and insulin secretory function of isolated human islets from cadaveric donorK S Park, Y S Kim, J H Kim, et al.
Skin Pharmacology and Applied Skin Physiology|September 10, 2002
Effect of glycolic acid on UVB-induced skin damage and inflammation in guinea pigsK S Park, H J Kim, E J Kim, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, U Tamura, et al.
International Journal of Hematology|December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study GroupT Ueda, S Miyawaki, N Asou, et al.
Pageof 172